Browse
Submit Data
Databases
API
Help

Dataset Information

10 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

From small structural modifications to adjustment of structurally dependent properties: 1-methyl-3,5-bis[(E)-2-thienylidene]-4-piperidone and 3,5-bis[(E)-5-bromo-2-thienylidene]-1-methyl-4-piperidone.

ABSTRACT: The molecules of the title compounds, C(16)H(15)NOS(2), (I), and C(16)H(13)Br(2)NOS(2), (II), are E,E-isomers and consist of an extensive conjugated system, which determines their molecular geometries. Compound (I) crystallizes in the monoclinic space group P2(1)/c. It has one thiophene ring disordered over two positions, with a minor component contribution of 0.100 (3). Compound (II) crystallizes in the noncentrosymmetric orthorhombic space group Pca2(1) with two independent molecules in the unit cell. These molecules are related by a noncrystallographic pseudo-inversion center and possess very similar geometries. The crystal packings of (I) and (II) have a topologically common structural motif, viz. stacks along the b axis, in which the molecules are bound by weak C-H...O hydrogen bonds. The noncentrosymmetric packing of (II) is governed by attractive intermolecular Br...Br and Br...N interactions, which are also responsible for the very high density of (II) (1.861 Mg m(-3)).

SUBMITTER: Tongwa P

PROVIDER: S-EPMC2665971 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

1-Benzyl-3,5-bis-(2-thienylmethyl-ene)-4-piperidone.

Project description:In the title compound, C(22)H(19)NOS(2), the thio-phene rings form angles of 69.74?(18) and 65.56?(16)° with the benzene ring. The piperidone ring adopts a half-chair conformation due to the presence of the conjugated ketone systems. Both thio-phene rings are disordered over two orientations [occupancies of 0.758?(2)/0.242?(2) and 0.588?(2)/0.412?(2)] at 180° from one another. In the crystal, weak inter-molecular C-H?O hydrogen bonds, C-H?? and aromatic ?-? stacking inter-actions [shortest centroid-centroid separation = 3.865?(3)?Å] help to stabilize the packing.

| S-EPMC2970328 | biostudies-literature

Crystal structures of methyl 3,5-di-methyl-benzoate, 3,5-bis-(bromo-meth-yl)phenyl acetate and 5-hy-droxy-benzene-1,3-dicarbaldehyde.

Project description:The crystal structures of the title compounds, methyl 3,5-di-methyl-benzoate (C10H12O2; 1), 3,5-bis-(bromo-meth-yl)phenyl acetate (C10H10Br2O2; 2) and 5-hy-droxy-benzene-1,3-dicarbaldehyde (C8H6O3; 3) were determined by single-crystal X-ray analysis. The crystals of 1 are composed of strands of C-H⋯O=C bonded mol-ecules, which are further arranged into layers. As a result of the presence of two bromo-methyl substituents in compound 2, mol-ecular dimers formed by crystallographically non-equivalent mol-ecules are connected to structurally different two-dimensional aggregates in which the bromine atoms participate in Br⋯Br bonds of type I and type II. In the case of compound 3, which possesses three donor/acceptor substituents, the mol-ecular association in the crystal creates a close three-dimensional network comprising Car-yl-H⋯Ohy-droxy, Cform-yl-H⋯Oform-yl and O-H⋯Oform-yl bonds.

| S-EPMC9260362 | biostudies-literature

Crystal structures of methyl 3,5-di-bromo-4-cyano-benzoate and methyl 3,5-di-bromo-4-iso-cyano-benzoate.

Project description:The title crystals, C9H5Br2NO2, are the first reported 2,6-dihalophenyl cyanide-isocyanide pair that have neither three- nor two-dimensional isomorphism. Both crystals contain contacts between the carbonyl O atom and a Br atom. In the crystal of the cyanide, R22(10) inversion dimers form based on C≡N⋯Br contacts, a common packing feature in this series of crystals. In the isocyanide, the corresponding N≡C⋯Br contacts are not observed. Instead, the iso-cyano C atom forms contacts with the meth-oxy C atom. RNC was refined as a two-component pseudo-merohedral twin.

| S-EPMC5947800 | biostudies-literature

(?-4-Bromo-3,5-dimethyl-pyrazolato-?(2)N(1):N(2))-?-chlorido-bis-[bis(4-bromo-3,5-dimethyl-pyrazole-?N(2))chloridocopper(II)] acetonitrile monosolvate.

Project description:In the title dinuclear complex, [Cu(2)(C(5)H(6)BrN(2))Cl(3)(C(5)H(7)BrN(2))(4)]·CH(3)CN, both Cu(II) ions are in slightly distorted square-pyramidal coordination geometries. The basal planes are defined by three N atoms from three 4-bromo-3,5-dimethyl-pyrazolate ligands, one of which is bridging, and one Cl ligand. A bridging Cl ligand forms the apical site for both Cu(II) ions. In the crystal, N-H?Cl hydrogen bonds connect complex mol-ecules into chains along [100]. Intra-molecular N-H?Cl hydrogen bonds are also observed.

| S-EPMC3344311 | biostudies-literature

3,5-bis(2,4-difluorobenzylidene)-4-piperidone, a novel compound that affects pancreatic cancer growth and angiogenesis.

Project description:Dysregulated Notch signaling plays an important role in the progression of cancer. Notch signaling affects tumor growth and angiogenesis through the actions of its ligand Jagged-1. In this study, we developed a novel compound 3,5-bis(2,4-difluorobenzylidene)-4-piperidone (DiFiD) and determined that it inhibits cancer cell growth and its effects on Notch signaling. Intraperitoneal administration of DiFiD significantly suppressed growth of pancreatic cancer tumor xenografts. There was a reduction in CD31-positive blood vessels, suggesting that there was an effect on angiogenesis. In vitro, DiFiD inhibited the proliferation of various human and mouse pancreatic cancer cells while increasing activated caspase-3. Cell-cycle analyses showed that DiFiD induced G(2)-M arrest and decreased the expression of cell-cycle-related proteins cyclin A1 and D1 while upregulating cyclin-dependent kinase inhibitor p21WAF1. We next determined the mechanism of action. DiFiD reduced Notch-1 activation, resulting in reduced expression of its downstream target protein Hes-1. We further determined that the reduced Notch-1 activation was due to reduction in the ligand Jagged-1 and two critical components of the ?-secretase enzyme complex presenilin-1 and nicastrin. Ectopic expression of the Notch intracellular domain rescued the cells from DiFiD-mediated growth suppression. DiFiD-treated tumor xenografts also showed reduced levels of Jagged-1 and the ?-secretase complex proteins presenilin-1 and nicastrin. Taken together, these data suggest that DiFiD is a novel potent therapeutic agent that can target different aspects of the Notch signaling pathway to inhibit both tumor growth and angiogenesis.

| S-EPMC3213278 | biostudies-literature

Inhibition of the NF-?B signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties.

Project description:Nuclear factor kappa B (NF-?B) is a key signaling molecule in the elaboration of the inflammatory response. Data indicate that curcumin, a natural ingredient of the curry spice turmeric, acts as a NF-?B inhibitor and exhibits both anti-inflammatory and anti-cancer properties. Curcumin analogs with enhanced activity on NF-?B and other inflammatory signaling pathways have been developed including the synthetic monoketone compound 3,5-Bis(2-fluorobenzylidene)-4-piperidone (EF24). 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31) is a structurally-related curcumin analog whose potency for NF-?B inhibition has yet to be determined. To examine the activity of EF31 compared to EF24 and curcumin, mouse RAW264.7 macrophages were treated with EF31, EF24, curcumin (1-100 ?M) or vehicle (DMSO 1%) for 1h. NF-?B pathway activity was assessed following treatment with lipopolysaccharide (LPS) (1 ?g/mL). EF31 (IC(50)~5 ?M) exhibited significantly more potent inhibition of LPS-induced NF-?B DNA binding compared to both EF24 (IC(50)~35 ?M) and curcumin (IC(50) >50 ?M). In addition, EF31 exhibited greater inhibition of NF-?B nuclear translocation as well as the induction of downstream inflammatory mediators including pro-inflammatory cytokine mRNA and protein (tumor necrosis factor-?, interleukin-1?, and interleukin-6). Regarding the mechanism of these effects on NF-?B, EF31 (IC(50)~1.92 ?M) exhibited significantly greater inhibition of I?B kinase ? compared to EF24 (IC(50)~131 ?M). Finally, EF31 demonstrated potent toxicity in NF-?B-dependent cancer cell lines while having minimal and reversible toxicity in RAW264.7 macrophages. These data indicate that EF31 is a more potent inhibitor of NF-?B activity than either EF24 or curcumin while exhibiting both anti-inflammatory and anticancer activities. Thus, EF31 represents a promising curcumin analog for further therapeutic development.

| S-EPMC3372981 | biostudies-literature

[Sulfonyl-bis-(bromo-methyl-ene)]di-benzene.

Project description:The title compound, C14H12Br2O2S, crystallizes as the meso isomer of a diastereoisomeric pair. This structure determination was key to determining that the 1,3 elimination of bromine by tri-phenyl-phosphine occurs with inversion of the configuration at each of the two chiral carbon atoms. In the crystal, the molecules are linked by weak C-H⋯O and C-H⋯Br hydrogen bonds.

| S-EPMC9028549 | biostudies-literature

2,2-Bis[3,5-bis-(di-methyl-amino)-phen-yl]-1,1,1,3,3,3-hexa-methyl-tris-ilane.

Project description:The title compound, C26H48N4Si3, was synthesized by the reaction of 2,2-di-chloro-tris-ilane with 3,5-bis-(di-methyl-amino)-phenyl-lithium. In the mol-ecule, the dihedral angle between the benzene rings is 57.57 (7)° and the Si-Si-Si bond angle is 110.08 (2)°. In the crystal, mol-ecules are linked via an SiC-H⋯π(ar-yl) inter-action, forming a chain along the c-axis direction.

| S-EPMC9462273 | biostudies-literature

Methyl 3,5-bis(cyclo-hexyl-meth-oxy)benzoate.

Project description:In the title compound, C22H32O4, the atoms of the methyl ester group and the alk-oxy O atoms are all coplanar with the central aromatic ring, with an r.m.s. deviation of 0.008 Å. Bonds to the methyl-ene and cyclo-hexyl groups are also very close to this plane, so that the mol-ecule is essentially flat, apart from the cyclo-hexyl groups. The mean planes through the cyclo-hexyl groups are tilted by 30.08 (9) and 36.14 (7)° with respect to the central aromatic ring. In the crystal, pairs of mol-ecules linked by C-H⋯O hydrogen bonds form planar units which are stacked along the a axis, with an average inter-planar distance of 3.549 (2) Å. Stacking appears to be stabilized by further weak C-H⋯O hydrogen bonds.

| S-EPMC3998623 | biostudies-literature

Bis(2-bromo-5-methyl-phen-oxy)methane.

Project description:The complete mol-ecule of the title compund, C(15)H(14)Br(2)O(2), is generated by the application of crystallographic twofold symmetry, with the central C atom lying on the rotation axis. The dihedral angle between the benzene rings is 62.4 (3)°. In the crystal, short Br⋯Br contacts [3.4885 (16) Å] occur.

| S-EPMC3200963 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data